أعرض في EDS

Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO

التفاصيل البيبلوغرافية
العنوان: Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO
المؤلفون: H. Orfeuvre, Dominique Berton-Rigaud, I.L. Ray-Coquard, M. Baron, Delphine Mollon, A.M. Savoye, Rémy Largillier, P.-E. Cailleux, A. Marti, Patricia Pautier, J.-B. Paoli, J.-L. Mouysset, Eric Pujade-Lauraine, W. Lescaut, Anne Floquet, H. Barletta, Frédéric Selle, M. C. Kaminsky, C. Cornea
المصدر: Annals of Oncology. 27:vi308
بيانات النشر: Elsevier BV, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Oncology, Gynecology, medicine.medical_specialty, Bevacizumab, business.industry, First line, Hematology, medicine.disease, Internal medicine, Cohort, Medicine, In real life, business, Ovarian cancer, medicine.drug
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d6145b8fb65f708e70904f1b818367b4
https://doi.org/10.1093/annonc/mdw374.42
حقوق: OPEN
رقم الأكسشن: edsair.doi...........d6145b8fb65f708e70904f1b818367b4
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534